Working to Eradicate Gynecologic Cancers

Petar Jelinic, PhD

PhD
Memorial Sloan Kettering Cancer Center
York Avenue
New York, NY
USA 10065

Papers:
191 - Poster Session A PD-0332991, a cyclin-dependent kinase 4/6 inhibitor, is an active agent in uterine cancer cells 265 - Poster Session A Somatic mutations in small cell carcinoma of the ovary Late Breaking Abstract 4 SMARCA4 Mutations in Small Cell Carcinoma of the Ovary